{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:06:01Z","timestamp":1792512361123,"version":"4.5.0"},"reference-count":152,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["202122-BL\/20-21\/0411"],"award-info":[{"award-number":["202122-BL\/20-21\/0411"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.cellsig.2025.111647","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T17:04:26Z","timestamp":1738861466000},"page":"111647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["STING activation and overcoming the challenges associated with STING agonists using ADC (antibody-drug conjugate) and other delivery systems"],"prefix":"10.1016","volume":"128","author":[{"given":"Hitesh","family":"Vasiyani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhumika","family":"Wadhwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cellsig.2025.111647_bb0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cellsig.2025.111647_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2013.00028","article-title":"Mechanisms and insights into drug resistance in cancer","volume":"4","author":"Zahreddine","year":"2013","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111647_bb0015","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/cancers6031769","article-title":"Drug resistance in cancer: An overview","volume":"6","author":"Housman","year":"2014","journal-title":"Cancers (Basel)"},{"issue":"FEB","key":"10.1016\/j.cellsig.2025.111647_bb0020","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3389\/fimmu.2019.00168","article-title":"Cold tumors: a therapeutic challenge for immunotherapy","volume":"10","author":"Bonaventura","year":"2019","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111647_bb0025","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2024.13171","article-title":"CAR-T cell therapy: a breakthrough in traditional cancer treatment strategies (review)","volume":"29","author":"Sun","year":"2024","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cellsig.2025.111647_bb0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.coviro.2016.01.001","article-title":"Type I interferons in viral control and immune regulation","volume":"16","author":"Teijaro","year":"2016","journal-title":"Curr. Opin. Virol."},{"issue":"11","key":"10.1016\/j.cellsig.2025.111647_bb0035","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.7150\/thno.58390","article-title":"Turning cold tumors into hot tumors by improving T-cell infiltration","volume":"11","author":"Liu","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.cellsig.2025.111647_bb0040","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/bs.apha.2021.01.002","article-title":"Review of immune checkpoint inhibitors in immuno-oncology","volume":"91","author":"Jacob","year":"2021","journal-title":"Adv. Pharmacol."},{"issue":"OCT","key":"10.1016\/j.cellsig.2025.111647_bb0045","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.3389\/fimmu.2018.02379","article-title":"Pattern recognition receptors and the host cell death molecular machinery","volume":"9","author":"Amarante-Mendes","year":"2018","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111647_bb0050","first-page":"112","article-title":"DNA sensing in the innate immune response","volume":"35","author":"Briard","year":"2020","journal-title":"Physiology (Bethesda)"},{"issue":"3","key":"10.1016\/j.cellsig.2025.111647_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00018-022-04219-z","article-title":"Type I interferon-mediated tumor immunity and its role in immunotherapy","volume":"79","author":"Yu","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111647_bb0060","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/s12276-020-0416-y","article-title":"The cGAS\/STING\/TBK1\/IRF3 innate immunity pathway maintains chromosomal stability through regulation of p21 levels","volume":"52","author":"Basit","year":"2020","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111647_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-020-00916-z","article-title":"CGAS-STING, an important pathway in cancer immunotherapy","volume":"13","author":"Jiang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.cellsig.2025.111647_bb0070","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","article-title":"Innate immune recognition","volume":"20","author":"Janeway","year":"2002","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111647_bb0075","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.molcel.2013.05.022","article-title":"Cyclic GMP-AMP containing mixed phosphodiester linkages is An endogenous high-affinity ligand for STING","volume":"51","author":"Zhang","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cellsig.2025.111647_bb0080","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.sbi.2019.08.003","article-title":"cGAS and CD-NTase enzymes: structure, mechanism, and evolution","volume":"59","author":"Kranzusch","year":"2019","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111647_bb0085","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.immuni.2020.05.013","article-title":"Structures and mechanisms in the cGAS-STING innate immunity pathway","volume":"53","author":"Zhang","year":"2020","journal-title":"Immunity"},{"issue":"6403","key":"10.1016\/j.cellsig.2025.111647_bb0090","first-page":"704","article-title":"DNA-induced liquid phase condensation of cGAS activates innate immune signaling","volume":"361","author":"Du","year":"2018","journal-title":"Science (1979)"},{"issue":"7748","key":"10.1016\/j.cellsig.2025.111647_bb0095","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41586-019-0998-5","article-title":"Cryo-EM structures of STING reveal its mechanism of activation by cyclic GMP\u2013AMP","volume":"567","author":"Shang","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111647_bb0100","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bpj.2017.10.027","article-title":"Dynamic structural differences between human and mouse STING Lead to differing sensitivity to DMXAA","volume":"114","author":"Shih","year":"2018","journal-title":"Biophys. J."},{"issue":"9","key":"10.1016\/j.cellsig.2025.111647_bb0105","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41580-020-0244-x","article-title":"Molecular mechanisms and cellular functions of cGAS\u2013STING signalling","volume":"21","author":"Hopfner","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.cellsig.2025.111647_bb0110","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11932","article-title":"Activation of STING requires palmitoylation at the Golgi","volume":"7","author":"Mukai","year":"2016","journal-title":"Nat. Commun."},{"issue":"7747","key":"10.1016\/j.cellsig.2025.111647_bb0115","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41586-019-1006-9","article-title":"Autophagy induction via STING trafficking is a primordial function of the cGAS pathway","volume":"567","author":"Gui","year":"2019","journal-title":"Nature"},{"issue":"6121","key":"10.1016\/j.cellsig.2025.111647_bb0120","first-page":"786","article-title":"Cyclic GMP\u2013AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway","volume":"339","author":"Sun","year":"2013","journal-title":"Science (1979)"},{"key":"10.1016\/j.cellsig.2025.111647_bb0125","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-3-030-17864-2_2","article-title":"MHC\/HLA class I loss in cancer cells","volume":"1151","author":"Garrido","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"issue":"8","key":"10.1016\/j.cellsig.2025.111647_bb0130","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41422-020-0343-4","article-title":"Immune checkpoint signaling and cancer immunotherapy","volume":"30","author":"He","year":"2020","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111647_bb0135","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10549-013-2618-7","article-title":"Myeloid derived suppressor cells in breast Cancer","volume":"140","author":"Markowitz","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"issue":"FEB","key":"10.1016\/j.cellsig.2025.111647_bb0140","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fimmu.2019.00172","article-title":"MDSCs: key criminals of tumor pre-metastatic niche formation","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111647_bb0145","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41416-018-0333-1","article-title":"Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression","volume":"120","author":"Groth","year":"2019","journal-title":"Br. J. Cancer"},{"issue":"30","key":"10.1016\/j.cellsig.2025.111647_bb0150","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.18632\/oncotarget.27673","article-title":"cGAS-STING pathway in oncogenesis and cancer therapeutics","volume":"11","author":"da Hoong","year":"2020","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellsig.2025.111647_bb0155","article-title":"Topoisomerase II inhibitors induce cGAS-STING dependent inflammation resulting in cytokine induction and immune checkpoint activation","author":"Wilkinson","year":"2019","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111647_bb0160","doi-asserted-by":"crossref","DOI":"10.1038\/s41421-020-0162-2","article-title":"Phosphorylation of cGAS by CDK1 impairs self-DNA sensing in mitosis","volume":"6","author":"Zhong","year":"2020","journal-title":"Cell Discov."},{"issue":"7","key":"10.1016\/j.cellsig.2025.111647_bb0165","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/s41556-022-00950-8","article-title":"Stalled replication fork protection limits cGAS-STING and P-body-dependent innate immune signalling","volume":"24","author":"Emam","year":"2022","journal-title":"Nat. Cell Biol."},{"issue":"42","key":"10.1016\/j.cellsig.2025.111647_bb0170","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb8941","article-title":"cGAS suppresses genomic instability as a decelerator of replication forks","volume":"6","author":"Chen","year":"2020","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111647_bb0175","article-title":"Cholesterol-binding motifs in STING that control endoplasmic reticulum retention mediate anti-tumoral activity of cholesterol-lowering compounds","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"issue":"7668","key":"10.1016\/j.cellsig.2025.111647_bb0180","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature23449","article-title":"cGAS surveillance of micronuclei links genome instability to innate immunity","volume":"548","author":"Mackenzie","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cellsig.2025.111647_bb0185","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.molimm.2020.12.037","article-title":"DNA damage-triggered activation of cGAS-STING pathway induces apoptosis in human keratinocyte HaCaT cells","volume":"131","author":"Li","year":"2021","journal-title":"Mol. Immunol."},{"issue":"11","key":"10.1016\/j.cellsig.2025.111647_bb0190","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1172\/JCI127471","article-title":"CGAS\/STING axis mediates a topoisomerase II inhibitor\u2013induced tumor immunogenicity","volume":"129","author":"Wang","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111647_bb0195","article-title":"Activation of STING-dependent innate immune signaling by S-phase-specific DNA damage in breast Cancer","volume":"109","author":"Ee","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"issue":"7689","key":"10.1016\/j.cellsig.2025.111647_bb0200","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nature25432","article-title":"Chromosomal instability drives metastasis through a cytosolic DNA response","volume":"553","author":"Sf","year":"2018","journal-title":"Nature"},{"issue":"7918","key":"10.1016\/j.cellsig.2025.111647_bb0205","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41586-022-04847-2","article-title":"cGAS-STING drives the IL-6-dependent survival of chromosomally instable cancers","volume":"607","author":"Hong","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111647_bb0210","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2044103","article-title":"IFN-\u03b3 activates the tumor cell-intrinsic STING pathway through the induction of DNA damage and cytosolic dsDNA formation","volume":"11","author":"Xiong","year":"2022","journal-title":"Oncoimmunology"},{"issue":"5","key":"10.1016\/j.cellsig.2025.111647_bb0215","doi-asserted-by":"crossref","DOI":"10.1007\/s12032-024-02326-4","article-title":"Combination of IFN-gamma with STING agonist and PD-1 immune checkpoint blockade: a potential immunotherapy for gastric cancer","volume":"41","author":"Hosseinzadeh","year":"2024","journal-title":"Med. Oncol."},{"key":"10.1016\/j.cellsig.2025.111647_bb0220","article-title":"Role of the cGAS-STING pathway in radiotherapy for non-small cell lung cancer","author":"Yang","year":"2023","journal-title":"BioMed. Cent. Ltd."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111647_bb0225","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.ijrobp.2021.12.162","article-title":"Radiation therapy promotes hepatocellular carcinoma immune cloaking via PD-L1 upregulation induced by cGAS-STING activation","volume":"112","author":"Du","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111647_bb0230","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.molcel.2018.07.034","article-title":"Non-canonical activation of the DNA sensing adaptor STING by ATM and IFI16 mediates NF-\u03baB signaling after nuclear DNA damage","volume":"71","author":"Dunphy","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cellsig.2025.111647_bb0235","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.709618","article-title":"Pharmacological targeting of STING-dependent IL-6 production in cancer cells","volume":"9","author":"Al-Asmari","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"11\u201312","key":"10.1016\/j.cellsig.2025.111647_bb0240","article-title":"DNA damage induces STING mediated IL-6-STAT3 survival pathway in triple-negative breast cancer cells and decreased survival of breast cancer patients","volume":"27","author":"Vasiyani","year":"2022","journal-title":"Apoptosis"},{"issue":"11","key":"10.1016\/j.cellsig.2025.111647_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2022.03.034","article-title":"Cytoplasmic PARP1 links the genome instability to the inhibition of antiviral immunity through PARylating cGAS","volume":"82","author":"Wang","year":"2022","journal-title":"Mol. Cell"},{"issue":"494","key":"10.1016\/j.cellsig.2025.111647_bb0250","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax9557","article-title":"PARP inhibitors need an extra STING for therapeutic efficacy","volume":"11","author":"Jeyasekharan","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"11","key":"10.1016\/j.cellsig.2025.111647_bb0255","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1016\/j.celrep.2018.11.054","article-title":"PARP inhibition elicits STING-dependent antitumor immunity in Brca1-deficient ovarian Cancer","volume":"25","author":"Ding","year":"2018","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111647_bb0260","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1172\/JCI123319","article-title":"PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer","volume":"129","author":"Chabanon","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellsig.2025.111647_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216676","article-title":"PARP inhibitor plus radiotherapy reshape the immune suppressive microenvironment and potentiate the efficacy of immune checkpoint inhibitors in tumors with IDH1 mutation","volume":"586","author":"Hu","year":"2024","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111647_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-023-06303-z","article-title":"Novel dual inhibitors of PARP and HDAC induce intratumoral STING-mediated antitumor immunity in triple-negative breast cancer","volume":"15","author":"Zhu","year":"2024","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111647_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41523-022-00471-5","article-title":"STING agonism enhances anti-tumor immune responses and therapeutic efficacy of PARP inhibition in BRCA-associated breast cancer","volume":"8","author":"Pantelidou","year":"2022","journal-title":"npj Breast Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111647_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-01883-9","article-title":"DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells","volume":"8","author":"Sato","year":"2017","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111647_bb0285","doi-asserted-by":"crossref","DOI":"10.1172\/JCI139333","article-title":"ATM inhibition enhances cancer immunotherapy by promoting mtDNA leakage and cGAS\/STING activation","volume":"131","author":"Hu","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.cellsig.2025.111647_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-024-06911-3","article-title":"ATM inhibition enhance immunotherapy by activating STING signaling and augmenting MHC class I","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111647_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-023-05412-x","article-title":"DNA damage induced by CDK4 and CDK6 blockade triggers anti-tumor immune responses through cGAS-STING pathway","volume":"6","author":"Fan","year":"2023","journal-title":"Commun. Biol."},{"issue":"11","key":"10.1016\/j.cellsig.2025.111647_bb0300","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1111\/cas.15961","article-title":"Combination of PARP inhibitor and CDK4\/6 inhibitor modulates cGAS\/STING-dependent therapy-induced senescence and provides \u2018one-two punch\u2019 opportunity with anti-PD-L1 therapy in colorectal cancer","volume":"114","author":"Wang","year":"2023","journal-title":"Cancer Sci."},{"issue":"16","key":"10.1016\/j.cellsig.2025.111647_bb0305","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1158\/0008-5472.CAN-23-3704","article-title":"CDK4\/6 alters TBK1 phosphorylation to inhibit the STING signaling pathway in prostate Cancer","volume":"84","author":"Li","year":"2024","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.cellsig.2025.111647_bb0310","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj2102","article-title":"IRF3 activates RB to authorize cGAS-STING\u2013induced senescence and mitigate liver fibrosis","volume":"10","author":"Wu","year":"2024","journal-title":"Sci. Adv."},{"issue":"8","key":"10.1016\/j.cellsig.2025.111647_bb0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0255787","article-title":"Role of metal complexation on the solubility and enzymatic hydrolysis of phytate","volume":"16","author":"Sun","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2025.111647_bb0320","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/bs.ai.2019.11.007","article-title":"Metalloimmunology: the metal ion-controlled immunity","volume":"145","author":"Wang","year":"2020","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.cellsig.2025.111647_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2018.03.017","article-title":"Manganese increases the sensitivity of the cGAS-STING pathway for double-stranded DNA and is required for the host defense against DNA viruses in brief","volume":"48","author":"Wang","year":"2018","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.cellsig.2025.111647_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108053","article-title":"Mn2+ directly activates cGAS and structural analysis suggests Mn2+ induces a noncanonical catalytic synthesis of 2\u20193\u2019-cGAMP","volume":"32","author":"Zhao","year":"2020","journal-title":"Cell Rep."},{"issue":"11","key":"10.1016\/j.cellsig.2025.111647_bb0335","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s41422-020-00395-4","article-title":"Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy","volume":"30","author":"Lv","year":"2020","journal-title":"Cell Res."},{"issue":"11","key":"10.1016\/j.cellsig.2025.111647_bb0340","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/s41565-021-00962-9","article-title":"Amplifying STING activation by cyclic dinucleotide-manganese particles for local and systemic Cancer Metalloimmunotherapy","volume":"16","author":"Sun","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"8","key":"10.1016\/j.cellsig.2025.111647_bb0345","article-title":"A manganese phosphate nanocluster activates the cGAS-STING pathway for enhanced Cancer immunotherapy","volume":"4","author":"Gao","year":"2021","journal-title":"Adv. Ther. (Weinh.)"},{"issue":"12","key":"10.1016\/j.cellsig.2025.111647_bb0350","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1158\/1535-7163.MCT-21-0195","article-title":"Paclitaxel induces micronucleation and activates pro-inflammatory cGAS-STING signaling in triple-negative breast cancer","volume":"20","author":"Hu","year":"2021","journal-title":"Mol. Cancer Ther."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111647_bb0355","doi-asserted-by":"crossref","DOI":"10.3390\/ph16050749","article-title":"S-72, a novel orally available tubulin inhibitor, overcomes paclitaxel resistance via inactivation of the STING pathway in breast cancer","volume":"16","author":"Hou","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"issue":"23","key":"10.1016\/j.cellsig.2025.111647_bb0360","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14235962","article-title":"The microtubule destabilizer Eribulin synergizes with STING agonists to promote antitumor efficacy in triple-negative breast Cancer models","volume":"14","author":"Takahashi-Ruiz","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111647_bb0365","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-13689-y","article-title":"STING-dependent paracriny shapes apoptotic priming of breast tumors in response to anti-mitotic treatment","volume":"11","author":"Lohard","year":"2020","journal-title":"Nat. Commun."},{"issue":"22","key":"10.1016\/j.cellsig.2025.111647_bb0370","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24224192","article-title":"ENPP1, an old enzyme with new functions, and small molecule inhibitors\u2014a STING in the tale of ENPP1","volume":"24","author":"Onyedibe","year":"2019","journal-title":"Molecules"},{"issue":"52","key":"10.1016\/j.cellsig.2025.111647_bb0375","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2313693120","article-title":"ENPP1 is an innate immune checkpoint of the anticancer cGAMP\u2013STING pathway in breast cancer","volume":"120","author":"Wang","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cellsig.2025.111647_bb0380","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.molimm.2018.01.008","article-title":"Maintenance of cyclic GMP\u2013AMP homeostasis by ENPP1 is involved in pseudorabies virus infection","volume":"95","author":"Wang","year":"2018","journal-title":"Mol. Immunol."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111647_bb0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245733","article-title":"High expression of ENPP1 in high-grade serous ovarian carcinoma predicts poor prognosis and as a molecular therapy target","volume":"16","author":"Wang","year":"2021","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.cellsig.2025.111647_bb0390","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1158\/2159-8290.CD-20-0387","article-title":"Metastasis and immune evasion from extracellular cGAMP hydrolysis","volume":"11","author":"Li","year":"2021","journal-title":"Cancer Discov."},{"issue":"20","key":"10.1016\/j.cellsig.2025.111647_bb0395","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202308131","article-title":"Tumor Exosomal ENPP1 hydrolyzes cGAMP to inhibit cGAS-STING signaling","volume":"11","author":"An","year":"2024","journal-title":"Adv. Sci."},{"issue":"12","key":"10.1016\/j.cellsig.2025.111647_bb0400","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nchembio.1661","article-title":"Hydrolysis of 2\u20323\u2032-cGAMP by ENPP1 and design of non-hydrolyzable analogs","volume":"10","author":"Li","year":"2014","journal-title":"Nat. Chem. Biol."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111647_bb0405","doi-asserted-by":"crossref","first-page":"292","DOI":"10.18632\/oncotarget.27886","article-title":"Intratumoral immunotherapy with STING agonist, ADU-S100, induces CD8+ T-cell mediated anti-tumor immunity in an esophageal adenocarcinoma model","volume":"12","author":"Zaidi","year":"2021","journal-title":"Oncotarget"},{"issue":"12_Supplement","key":"10.1016\/j.cellsig.2025.111647_bb0410","doi-asserted-by":"crossref","DOI":"10.1158\/1535-7163.TARG-21-LBA009","article-title":"Abstract LBA009: orally available ENPP1 inhibitor, TXN10128, restores STING activation in tumor microenvironment and confers anti-tumor responses in combination with immune checkpoint blockade","volume":"20","author":"Kim","year":"2021","journal-title":"Mol. Cancer Ther."},{"issue":"16_suppl","key":"10.1016\/j.cellsig.2025.111647_bb0415","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.16_suppl.e14550","article-title":"First-in-human experience using RBS2418, an oral ENPP1 inhibitor within an expanded access protocol in combination with pembrolizumab in a patient with metastatic adrenal cancer","volume":"40","author":"Csiki","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cellsig.2025.111647_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.116006","article-title":"Targeting ENPP1 for cancer immunotherapy: killing two birds with one stone","volume":"220","author":"Huang","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cellsig.2025.111647_bb0425","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1070492","article-title":"Human antibodies targeting ENPP1 as candidate therapeutics for cancers","volume":"14","author":"Chu","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111647_bb0430","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41589-023-01368-5","article-title":"Discovery of VH domains that allosterically inhibit ENPP1","volume":"20","author":"Solomon","year":"2023","journal-title":"Nat. Chem. Biol."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111647_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114209","article-title":"Identification of the extracellular membrane protein ENPP3 as a major cGAMP hydrolase and innate immune checkpoint","volume":"43","author":"Mardjuki","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.cellsig.2025.111647_bb0440","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/164_2015_43","article-title":"The chemistry of the noncanonical cyclic dinucleotide 2\u20193\u2019-cGAMP and its analogs","volume":"238","author":"Schwede","year":"2017","journal-title":"Handb. Exp. Pharmacol."},{"issue":"9","key":"10.1016\/j.cellsig.2025.111647_bb0445","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1158\/2326-6066.CIR-13-0123","article-title":"STING ligand c-di-GMP improves cancer vaccination against metastatic breast cancer","volume":"2","author":"Chandra","year":"2014","journal-title":"Cancer Immunol. Res."},{"issue":"12","key":"10.1016\/j.cellsig.2025.111647_bb0450","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1128\/IAI.00447-16","article-title":"Cyclic di-AMP released from Staphylococcus aureus biofilm induces a macrophage type I interferon response","volume":"84","author":"Gries","year":"2016","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111647_bb0455","article-title":"Cyclic di-GMP regulates mycobacterium tuberculosis resistance to ethionamide","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111647_bb0460","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1365-2958.2004.04155.x","article-title":"Cyclic diguanylate (c-di-GMP) regulates vibrio cholerae biofilm formation","volume":"53","author":"Tischler","year":"2004","journal-title":"Mol. Microbiol."},{"issue":"5\u20136","key":"10.1016\/j.cellsig.2025.111647_bb0465","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10495-021-01669-x","article-title":"The analog of cGAMP, c-di-AMP, activates STING mediated cell death pathway in estrogen-receptor negative breast cancer cells","volume":"26","author":"Vasiyani","year":"2021","journal-title":"Apoptosis"},{"issue":"12","key":"10.1016\/j.cellsig.2025.111647_bb0470","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.210277","article-title":"Au naturale: use of biologically derived cyclic di-nucleotides for cancer immunotherapy","volume":"11","author":"Waters","year":"2021","journal-title":"Open Biol."},{"issue":"6","key":"10.1016\/j.cellsig.2025.111647_bb0475","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099988","article-title":"DMXAA causes tumor site-specific vascular disruption in murine non-small cell lung Cancer, and like the endogenous non-canonical cyclic dinucleotide STING agonist, 2\u20323\u2032-cGAMP, induces M2 macrophage repolarization","volume":"9","author":"Downey","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.cellsig.2025.111647_bb0480","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1346765","article-title":"The STING agonist DMXAA triggers a cooperation between T lymphocytes and myeloid cells that leads to tumor regression","volume":"6","author":"Weiss","year":"2017","journal-title":"Oncoimmunology"},{"issue":"4","key":"10.1016\/j.cellsig.2025.111647_bb0485","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1158\/1078-0432.CCR-21-1963","article-title":"Phase I dose-Escalation trial of MIW815 (ADU-S100), an Intratumoral STING agonist, in patients with advanced\/metastatic solid tumors or lymphomas","volume":"28","author":"Meric-Bernstam","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"4_Supplement","key":"10.1016\/j.cellsig.2025.111647_bb0490","doi-asserted-by":"crossref","DOI":"10.1158\/2326-6074.TUMIMM18-PR09","article-title":"Abstract PR09: ADU-S100 (MIW815) synergizes with checkpoint blockade to elicit an antitumor CD8+ T-cell response to control distal tumors","volume":"8","author":"Deng","year":"2020","journal-title":"Cancer Immunol. Res."},{"issue":"7","key":"10.1016\/j.cellsig.2025.111647_bb0495","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1021\/acs.jmedchem.1c02197","article-title":"Discovery of MK-1454: a potent cyclic dinucleotide stimulator of interferon genes agonist for the treatment of cancer","volume":"65","author":"Chang","year":"2022","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.cellsig.2025.111647_bb0500","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1016\/j.apsb.2020.03.001","article-title":"Small molecules targeting the innate immune cGAS\u2013STING\u2013TBK1 signaling pathway","volume":"10","author":"Ding","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"7736","key":"10.1016\/j.cellsig.2025.111647_bb0505","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41586-018-0705-y","article-title":"Design of amidobenzimidazole STING receptor agonists with systemic activity","volume":"564","author":"Ramanjulu","year":"2018","journal-title":"Nature"},{"issue":"15_suppl","key":"10.1016\/j.cellsig.2025.111647_bb0510","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.15_suppl.e14616","article-title":"Preclinical studies of SB 11285, a novel STING agonist for immuno-oncology","volume":"35","author":"Challa","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111647_bb0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-024-47692-9","article-title":"The STING agonist IMSA101 enhances chimeric antigen receptor T cell function by inducing IL-18 secretion","volume":"15","author":"Uslu","year":"2024","journal-title":"Nat. Commun."},{"issue":"16_Supplement","key":"10.1016\/j.cellsig.2025.111647_bb0520","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2020-5567","article-title":"Abstract 5567: in vivo administration of the STING agonist, JNJ-67544412, leads to complete regression of established murine subcutaneous tumors","volume":"80","author":"Smith","year":"2020","journal-title":"Cancer Res."},{"issue":"13_Supplement","key":"10.1016\/j.cellsig.2025.111647_bb0525","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2021-CT217","article-title":"Abstract CT217: phase I, first-in-human trial evaluating BI 1387446 (STING agonist) alone and in combination with ezabenlimab (BI 754091; anti-PD-1) in solid tumors","volume":"81","author":"Harrington","year":"2021","journal-title":"Cancer Res."},{"issue":"Supplement 1","key":"10.1016\/j.cellsig.2025.111647_bb0530","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2022-167652","article-title":"Sting agonist GSK3745417 induces apoptosis, Antiproliferation, and cell death in a panel of human AML cell lines and patient samples","volume":"140","author":"Adam","year":"2022","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cellsig.2025.111647_bb0535","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1021\/acs.oprd.4c00102","article-title":"The first GMP synthesis of MK-2118, a small molecule agonist for stimulator of interferon genes","volume":"28","author":"Lyons","year":"2024","journal-title":"Org. Process. Res. Dev."},{"issue":"Suppl. 2","key":"10.1016\/j.cellsig.2025.111647_bb0540","article-title":"495 trial of SNX281, a systemically delivered small molecule STING agonist, in solid tumors and lymphomas","volume":"9","author":"Wang","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"6","key":"10.1016\/j.cellsig.2025.111647_bb0545","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1158\/2767-9764.CRC-21-0161","article-title":"TAK-676: A Novel Stimulator of Interferon Genes (STING) Agonist Promoting Durable IFN-dependent Antitumor Immunity in Preclinical Studies","volume":"2","author":"Carideo Cunniff","year":"2022","journal-title":"Cancer Res. Commun."},{"issue":"11","key":"10.1016\/j.cellsig.2025.111647_bb0550","first-page":"1740","article-title":"E7766, a macrocycle-bridged stimulator of interferon genes (STING) agonist with potent Pan-genotypic activity","volume":"16","author":"Kim","year":"2021","journal-title":"ChemMedChem"},{"issue":"16_Supplement","key":"10.1016\/j.cellsig.2025.111647_bb0555","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2020-4532A","article-title":"Abstract 4532A: development of selective small molecule STING agonists suitable for systemic administration","volume":"80","author":"Chmielewski","year":"2020","journal-title":"Cancer Res."},{"issue":"6506","key":"10.1016\/j.cellsig.2025.111647_bb0560","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1126\/science.abb4255","article-title":"Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic","volume":"369","author":"Chin","year":"2020","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.cellsig.2025.111647_bb0565","first-page":"1","article-title":"Challenges and opportunities in the clinical development of STING agonists for Cancer immunotherapy","volume":"9","author":"Aval","year":"2020","journal-title":"J. Clin. Med."},{"issue":"22","key":"10.1016\/j.cellsig.2025.111647_bb0570","doi-asserted-by":"crossref","first-page":"10253","DOI":"10.1021\/acs.jmedchem.6b01300","article-title":"Design, synthesis, and biological evaluation of novel cyclic adenosine-inosine monophosphate (cAIMP) analogs that activate stimulator of interferon genes (STING)","volume":"59","author":"Lioux","year":"2016","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.cellsig.2025.111647_bb0575","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41571-021-00507-y","article-title":"Intratumoural administration and tumour tissue targeting of cancer immunotherapies","volume":"18","author":"Melero","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111647_bb0580","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4049\/jimmunol.1601145","article-title":"Intratumoral delivery of immunotherapy-act locally, think globally","volume":"198","author":"Aznar","year":"2017","journal-title":"J. Immunol."},{"issue":"25","key":"10.1016\/j.cellsig.2025.111647_bb0585","doi-asserted-by":"crossref","first-page":"7759","DOI":"10.7150\/thno.37574","article-title":"STING activation in cancer immunotherapy","volume":"9","author":"Su","year":"2019","journal-title":"Theranostics"},{"issue":"22","key":"10.1016\/j.cellsig.2025.111647_bb0590","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.1039\/D3SC01896B","article-title":"Photochemically controlled activation of STING by CAIX-targeting photocaged agonists to suppress tumor cell growth","volume":"14","author":"Ding","year":"2023","journal-title":"Chem. Sci."},{"issue":"9","key":"10.1016\/j.cellsig.2025.111647_bb0595","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41581-022-00589-6","article-title":"Role of the cGAS\u2013STING pathway in systemic and organ-specific diseases","volume":"18","author":"Skopelja-Gardner","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111647_bb0600","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202255536","article-title":"STING agonism turns human T cells into interferon-producing cells but impedes their functionality","volume":"24","author":"Kuhl","year":"2023","journal-title":"EMBO Rep."},{"issue":"7931","key":"10.1016\/j.cellsig.2025.111647_bb0605","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41586-022-05254-3","article-title":"STING-induced regulatory B cells compromise NK function in cancer immunity","volume":"610","author":"Li","year":"2022","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.cellsig.2025.111647_bb0610","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/s41565-019-0567-y","article-title":"Smart cancer nanomedicine","volume":"14","author":"van der Meel","year":"2019","journal-title":"Nat. Nanotechnol."},{"issue":"6","key":"10.1016\/j.cellsig.2025.111647_bb0615","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41578-019-0108-1","article-title":"Cancer nanomedicine for combination cancer immunotherapy","volume":"4","author":"Nam","year":"2019","journal-title":"Nat. Rev. Mater."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111647_bb0620","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14040883","article-title":"Nanocarrier drug delivery systems: characterization, limitations, future perspectives and implementation of artificial intelligence","volume":"14","author":"Alshawwa","year":"2022","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.cellsig.2025.111647_bb0625","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14081566","article-title":"Nanocarriers: a reliable tool for the delivery of anticancer drugs","volume":"14","author":"Sabit","year":"2022","journal-title":"Pharmaceutics"},{"issue":"13","key":"10.1016\/j.cellsig.2025.111647_bb0630","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23137104","article-title":"Development of novel Ecto-nucleotide pyrophosphatase\/phosphodiesterase 1 (ENPP1) inhibitors for tumor immunotherapy","volume":"23","author":"Wang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.cellsig.2025.111647_bb0635","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/s41563-022-01251-z","article-title":"STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity","volume":"21","author":"Dane","year":"2022","journal-title":"Nat. Mater."},{"key":"10.1016\/j.cellsig.2025.111647_bb0640","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ebiom.2019.02.055","article-title":"STING-mediated intestinal barrier dysfunction contributes to lethal sepsis","volume":"41","author":"Hu","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cellsig.2025.111647_bb0645","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.addr.2017.05.011","article-title":"Delivering safer immunotherapies for cancer","volume":"114","author":"Milling","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111647_bb0650","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jconrel.2014.04.004","article-title":"A new adjuvant delivery system \u2018cyclic di-GMP\/YSK05 liposome\u2019 for cancer immunotherapy","volume":"184","author":"Miyabe","year":"2014","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.cellsig.2025.111647_bb0655","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1172\/JCI87624","article-title":"Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors","volume":"127","author":"Smith","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"51","key":"10.1016\/j.cellsig.2025.111647_bb0660","doi-asserted-by":"crossref","first-page":"56741","DOI":"10.1021\/acsami.0c16728","article-title":"STING activator c-di-GMP-loaded mesoporous silica nanoparticles enhance immunotherapy against breast Cancer","volume":"12","author":"Chen","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"9","key":"10.1016\/j.cellsig.2025.111647_bb0665","article-title":"pH-responsive STING-activating DNA Nanovaccines for Cancer immunotherapy","volume":"3","author":"Zhang","year":"2020","journal-title":"Adv. Ther. (Weinh.)"},{"issue":"15","key":"10.1016\/j.cellsig.2025.111647_bb0670","doi-asserted-by":"crossref","first-page":"6723","DOI":"10.7150\/thno.71010","article-title":"Novel formulation of c-di-GMP with cytidinyl\/cationic lipid reverses T cell exhaustion and activates stronger anti-tumor immunity","volume":"12","author":"Yu","year":"2022","journal-title":"Theranostics"},{"issue":"41","key":"10.1016\/j.cellsig.2025.111647_bb0675","article-title":"Metal-cyclic dinucleotide Nanomodulator-stimulated STING signaling for strengthened Radioimmunotherapy of large tumor","volume":"18","author":"Wang","year":"2022","journal-title":"Small"},{"issue":"32","key":"10.1016\/j.cellsig.2025.111647_bb0680","article-title":"Systemic delivery of mPEG-masked Trispecific T-cell Nanoengagers in synergy with STING agonists overcomes immunotherapy resistance in TNBC and generates a vaccination effect","volume":"9","author":"Shen","year":"2022","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.cellsig.2025.111647_bb0685","article-title":"Peptide nanotube loaded with a STING agonist, c-di-GMP, enhance cancer immunotherapy against melanoma","author":"Zhang","year":"2022","journal-title":"Nano Res."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111647_bb0690","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24050941","article-title":"Recent advances in aptamer discovery and applications","volume":"24","author":"Zhang","year":"2019","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111647_bb0695","doi-asserted-by":"crossref","first-page":"111","DOI":"10.61935\/acetr.1.1.2023.P111","article-title":"Sequential delivery of aptamer and STING agonist shuttled by graphene oxide","volume":"1","author":"Zhang","year":"2023","journal-title":"Adv. Comput. Eng. Technol. Res."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111647_bb0700","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1021\/acscentsci.3c01310","article-title":"Mannosylated STING agonist Drugamers for dendritic cell-mediated Cancer immunotherapy","volume":"10","author":"Nguyen","year":"2024","journal-title":"ACS Cent. Sci."},{"issue":"8","key":"10.1016\/j.cellsig.2025.111647_bb0705","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41573-023-00709-2","article-title":"Antibody\u2013drug conjugates come of age in oncology","volume":"22","author":"Dumontet","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111647_bb0710","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41571-023-00850-2","article-title":"Exploring the next generation of antibody\u2013drug conjugates","volume":"21","author":"Tsuchikama","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"15","key":"10.1016\/j.cellsig.2025.111647_bb0715","doi-asserted-by":"crossref","first-page":"10715","DOI":"10.1021\/acs.jmedchem.3c00907","article-title":"Discovery and optimization of a STING agonist platform for application in antibody drug conjugates","volume":"66","author":"Duvall","year":"2023","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111647_bb0720","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-024-49932-4","article-title":"Tumor cell-directed STING agonist antibody-drug conjugates induce type III interferons and anti-tumor innate immune responses","volume":"15","author":"Malli Cetinbas","year":"2024","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111647_bb0725","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17040561","article-title":"Linkers having a crucial role in antibody\u2013drug conjugates","volume":"17","author":"Lu","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2025.111647_bb0730","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejps.2016.12.011","article-title":"Hydrazone linkages in pH responsive drug delivery systems","volume":"99","author":"Sonawane","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"issue":"49","key":"10.1016\/j.cellsig.2025.111647_bb0735","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2214278119","article-title":"Tumor-targeted delivery of a STING agonist improves cancer immunotherapy","volume":"119","author":"Wu","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6_Supplement","key":"10.1016\/j.cellsig.2025.111647_bb0740","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2024-6732","article-title":"Abstract 6732: immunomodulatory and anti-tumor effect of a CCR2-targeted STING agonist iADC in human lung cancer","volume":"84","author":"Porciuncula","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2025.111647_bb0745","series-title":"Regular and Young Investigator Award Abstracts","article-title":"1017\u00a0PSMA-E7766 ADC: harnessing targeted delivery of STING agonists for anti-tumor activity in prostate cancer","author":"Drozdowski","year":"2024"},{"issue":"4","key":"10.1016\/j.cellsig.2025.111647_bb0750","volume":"17","author":"Lu","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.cellsig.2025.111647_bb0755","article-title":"1114\u00a0targeted delivery of a potent STING agonist payload via an antibody drug conjugate drives robust antitumor activity in preclinical models","volume":"11","author":"Cummins","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111647_bb0760","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1541-7786.MCR-19-0582","article-title":"Antibody-drug conjugates: a comprehensive review","volume":"18","author":"Khongorzul","year":"2020","journal-title":"Mol. Cancer Res."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825000609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825000609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T21:10:03Z","timestamp":1740690603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656825000609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":152,"alternative-id":["S0898656825000609"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.111647","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"STING activation and overcoming the challenges associated with STING agonists using ADC (antibody-drug conjugate) and other delivery systems","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.111647","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111647"}}